16 results
PRE 14A
ATHA
Athira Pharma Inc
28 Mar 24
Preliminary proxy
8:47am
to the audit committee, including, but not limited to:
the benefits and perceived benefits to us;
the materiality and character of the related-person’s
DEFC14A
ATHA
Athira Pharma Inc
5 Apr 22
Proxy in contested solicitation
4:08pm
;
the materiality and character of the related-person’s direct and indirect interest;
the availability of other sources for comparable products or services
PREC14A
ATHA
Athira Pharma Inc
25 Mar 22
Preliminary proxy with contested solicitation
5:15pm
benefits to us;
the materiality and character of the related-person’s direct and indirect interest;
the availability of other sources for comparable
S-3
EX-5.1
jx8g 5zxvojkffm9
15 Nov 21
Shelf registration
4:06pm
DEF 14A
9m5wv mjjx
16 Apr 21
Definitive proxy
6:02am
10-K
v8yjzfnvk53hkb
25 Mar 21
Annual report
12:00am
424B4
u5kdfs n1qrv
21 Jan 21
Prospectus supplement with pricing info
12:00am
DRS
z2tu7kk6ygky7tqrrn8
6 Jan 21
Draft registration statement
12:00am
424B4
xo9lz4402mv88gx
18 Sep 20
Prospectus supplement with pricing info
4:05pm
S-1
zrusedlfi18rbi
26 Aug 20
IPO registration
5:25pm
DRS
za1h440f2q5dy4io 4ud
24 Jul 20
Draft registration statement
12:00am
- Prev
- 1
- Next